Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep90 | Adrenal and Cardiovascular Endocrinology | ECE2023

Multifocal paraganglioma due to SDHB mutation: On purpose of one clinical case

Ferreira-Ocampo Pablo , Doejo Marciales Sandra Carolina , Barra Malig Solange Fabiola , Astunague Condori Remy Edward , Chicharro Pablo Lois , Ruiz Francisca Almodovar , Gorgojo Martinez Juan Jose , Salinas Helena Requejo

The mutations of succinate dehydrogenase subunits (SDHA, SDHB, SDHC, SDHD) are linked with a predisposition to develop pheochromocytoma and paraganglioma, often in diferent locations of the body. With greater acces to genetic tests, current estimations suggest that 40-50% of pheocromocytoma and paraganglioma cases are inherited and half of them are due to SDH mutations. These mutations can be associated with other tumours like renal carcinomas, gastrointestinal stroma tumours ...

ea0070ep38 | Adrenal and Cardiovascular Endocrinology | ECE2020

Intracardiac paraganglioma in a patient with a paraganglioma syndrome type 4. Short, medium and long-term follow-up

Chicharro Pablo Lois , Wong Martín Jaime , Basagoiti Carreño Belén , Ferreira Ocampo Pablo José , Almdóvar Ruiz Francisca

Introduction: Paraganglioma type 4 is the second most common hereditary paraganglioma syndrome. It is due to a mutation in the succinate dehydrogenase B (SDHB) gene. Associated with high morbimortality for presenting high penetrance (77%) and debut at an early age with a high probability of malignancy (31–71%). In terms of follow-up, annual biochemical monitoring is recommended for mutation carriers. However, the affected gene should be taken into account, for example: t...